Skip to main content

Table 4 Patterns of recurrence and treatment

From: Salvage radiotherapy with simultaneous integrated boost in non small-cell lung cancer patients with mediastinal relapse after surgery: a pilot study

Patient

Age

Site of Boost Volume

CCT

Dosis SIB (Gy)

Volume/Volume SIB (cc)

Local relapse (boost)

Nodal regional relapse

Distant recurrence

Therapy after recurrence

1

78

2 L, 4 L, 5, 6

Yes

50/62.5

323.24/80

No

No

Lung, nodes

BSC

2

55

4R, 10R

Yes

50/62.5

166.48/52.43

No

7

Brain, bone

Palliative RT

3

67

4R, 5, 10R

No

50/62.5

213.81/14.91

No

No

  

4

78

rT, 10R

No

50/62.5

201.06/11.35

No

7 and 5

 

BSC

5

75

2R, 4R, 5

Yes

50/62.5

402.31/98.14

No

No

  

6

69

5, 6, 10 L

No

50/62.5

203.58/76.48

No

No

  

7

56

10R

Yes

50/62.5

64.16/5.42

No

No

  

8

55

2 L, 4R, 6

Yes

50/62.5

148.86/10.29

No

No

  

9

51

2R, 4R, 5, 7, 10R

No

50/62.5

313.01/193.46

No

No

  

10

57

2R, 4R, 5, 7, 10R

No

50/62.5

408.43/95

No

No

Brain

SRS 9 Gyx3

11

77

7

No

50/62.5

289.92/34.99

No

No

Liver

BSC

12

58

4R

Yes

50/62.5

141.27/95.95

No

No

Brain

3 SRS 20 Gy

13

69

4R, 10R

Yes

50/62.5

121.91/50.37

No

7

Bone

CT

14

69

4R

Yes

50/62.5

134.19/19.86

No

No

Lung, nodes

BSC

  1. CCT: concomitant chemotherapy, SIB: simultaneous integrated boost, CT: chemotherapy, RT: radiotherapy, BSC: best supportive care, SRS: stereotactic radiosurgery